Journal article
Cannabinoids for sleep disorders: Weeding through the evidence
Sleep medicine reviews, Vol.53, 101363
2020
PMID: 32781403
Abstract
Sleep disorders are common and include obstructive sleep apnoea (OSA), insomnia, parasomnias, movement disorders and neurological disorders such as narcolepsy. Consequences of untreated sleep disorders include cardiovascular disease, metabolic dysfunction, cognitive impairment and depression. The financial burden of sleep disorders is also significant with the total annual cost of undiagnosed OSA in the US alone estimated to be in excess of US$149b in 2015 [1]. It is estimated that US$100b per year would be saved if every adult with OSA in the US were diagnosed and treated...
Details
- Title
- Cannabinoids for sleep disorders: Weeding through the evidence
- Authors/Creators
- Jennifer H. Walsh - The University of Western AustraliaPeter R. Eastwood - West Australian Sleep Disorders Research Institute
- Publication Details
- Sleep medicine reviews, Vol.53, 101363
- Publisher
- Elsevier
- Number of pages
- 3
- Grant note
- 1136548 / National Health and Medical Research Council Senior Research Fellowship; National Health and Medical Research Council (NHMRC) of Australia
- Identifiers
- 991005592648807891
- Copyright
- © 2020 Elsevier Ltd
- Murdoch Affiliation
- Vice Chancellery
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
16 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.100 Substance Abuse
- 1.100.625 Cannabinoids
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior